Glypto Device, Glypto Cryo Machine; Recall
Glypto Device, Glypto Cryo Machine;
FDA recall Class II
Ongoing
FDA lists this Class II recall for Glypto Device, Glypto Cryo Machine;. Review the affected identifiers, reported reason and manufacturer instructions below.
Recall at a glance
- Recall number
- Z-0080-2027
- Recall classification
- Class II
- Enforcement status
- Ongoing
- Initiation date
- Aug 24, 2026
- FDA report date
- Oct 14, 2026
- Quantity in commerce
- 219
- Distribution
- See key details
- FDA cause
- Under Investigation by firm
What is being recalled?
Glypto Device, Glypto Cryo Machine;
The retrieved code information does not contain explicit model/GTIN pairs that this publication can reliably map.
Search FDA identifier text
Search a model, catalog, lot or UDI value exactly as printed in FDA’s product description or code information.
This search checks only the FDA product description and code information displayed on this page. It does not decode a UDI, normalize GTIN lengths or establish a relationship between separately listed codes.
FDA code information
All Glypto units distributed, placed, held, loaned, inventoried, or otherwise supplied by/through Limitless through the 08/11/2026 operational hold; 08/20/2026 preliminary field notice. Serial/account-specific consignee list attached or to be supplemented.
Why was this product recalled?
Lack of 510(k) clearance.
What actions did Limitless Cryo Spa LLC take?
On August 24, 2026, Urgent Medical Device Recall letters were sent to customers. Actions to be taken: 1. Stop using every Glypto device immediately. 2. Unplug the device, clearly mark or tag it as QUARANTINED / DO NOT USE, and secure it in a location where it cannot be used pending removal from your facility or other writte n disposition instructions from Limitless. 3. Do not open, clean, service, repair, modify, move, ship, return, sell, transfer, loan, discard, or destroy any Glypto device or component unless Limitless provides written recall instructions. 4. Complete and return the attached Recall Response Form by the response due date above, even if you no longer have the device. 5. Read the serial number or other identifier from the device label/nameplate if present and provide it on the response form. If no label/nameplate is present or it cannot be read, state that on the form and attach clear device photos. 6. Identify the current location and status of each Glypto device and whether it is in your possession, in customer possession, in storage, loaned out, transferred, returned, or no longer available. 7. If you sold, transferred, loaned, placed, or otherwise provided a Glypto device to another person or entity, stop any further distribution and provide Limitless with the downstream recipient's name, telephone number, email, and address. 8. Preserve all Glypto-related records, including purchase, sales, service, repair, training, complaint, adverse-event, refund, text, email, Slack/direct-message, and downstream distribution records. 9. Report any complaint, device problem, injury, medical visit, service/repair issue, workaround, or other safety concern involving a Glypto device to Limitless.
Read the manufacturer action recorded by FDARecall timeline
Recall initiated by firm
FDA notice posted
FDA classification recorded
FDA enforcement report date
Related FDA submissions
No submission number with an exact verified relationship is linked in the retrieved recall notice.
FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.
Source and update history
- FDA recall notice Z-0080-2027
- openFDA enforcement record · Source release Nov 11, 2026 · Retrieved Nov 19, 2026
- openFDA device recall record · Source release Nov 19, 2026 · Retrieved Nov 20, 2026
- FDA enforcement data
First stored snapshot of this source.
- FDA device-recall notice
First stored snapshot of this source.
The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.
Our data sources and methodology